18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study

被引：0

作者：

Emmanuel Ledoult

Maxime Morelle

Michael Soussan

Arsène Mékinian

Hélène Béhal

Vincent Sobanski

Eric Hachulla

Damien Huglo

Noémie Le Gouellec

Martine Remy-Jardin

Clio Baillet

David Launay

机构：

[1] Univ. Lille,

[2] INFINITE - Institute for Translational Research in Inflammation,undefined

[3] Univ. Lille,undefined

[4] CHU Lille,undefined

[5] Service de Médecine Interne,undefined

[6] Centre de Référence des Maladies Auto-immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO),undefined

[7] Inserm,undefined

[8] U1286,undefined

[9] Hôpital Claude Huriez,undefined

[10] Service de Médecine Interne,undefined

[11] CHU Lille,undefined

[12] Service de Médecine Nucléaire,undefined

[13] CH Avicenne – APHP,undefined

[14] Service de Médecine Nucléaire,undefined

[15] Hôpital Saint-Antoine – APHP,undefined

[16] Service de Médecine Interne,undefined

[17] Sorbonne Université,undefined

[18] Univ. Lille,undefined

[19] CHU Lille,undefined

[20] ULR 2694 - METRICS : Évaluation des technologies de santé et des pratiques médicales,undefined

[21] Univ. Lille,undefined

[22] Inserm,undefined

[23] CHU Lille,undefined

[24] U1189 - ONCO-THAI - Image Assisted Laser Therapy for Oncology,undefined

[25] CH Valenciennes,undefined

[26] Service de Médecine Interne,undefined

[27] Centre de Compétences adultes pour les maladies auto-immunes et systémiques rares,undefined

[28] Univ. Lille,undefined

[29] CHU Lille,undefined

[30] Service d’imagerie Thoracique,undefined

[31] Univ. Lille,undefined

[32] CHU Lille,undefined

[33] EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées,undefined

来源：

Arthritis Research & Therapy | / 23卷

关键词：

Systemic sclerosis; Interstitial lung disease; F-FDG PET/CT; Pulmonary function tests;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 228 条

[1]

Hachulla E(2011)Diagnosis and classification of systemic sclerosis Clin Rev Allergy Immunol 40 78-83

[2]

Launay D(2011)Scleroderma lung disease Clin Rev Allergy Immunol 40 104-116

[3]

Le Pavec J(2007)Changes in causes of death in systemic sclerosis, 1972-2002 Ann Rheum Dis 66 940-944

[4]

Launay D(2019)Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature Arthritis Res Ther 21 86-1586

[5]

Mathai SC(2002)Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome Am J Respir Crit Care Med 165 1581-2212

[6]

Hassoun PM(2015)Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis Arthritis Rheumatol 67 2205-1471

[7]

Humbert M(2015)Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling Rheumatology (Oxford) 54 1464-307

[8]

Steen VD(2019)Interstitial lung disease in systemic sclerosis: focus on early detection and intervention Open Access Rheumatol 11 283-3970

[9]

Medsger TA(2006)A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma Arthritis Rheum 54 3962-2666

[10]

Pokeerbux MR(2006)Cyclophosphamide versus placebo in scleroderma lung disease N Engl J Med 354 2655-1460

← 1 2 3 4 5 6 7 8 9 10 →